• Something wrong with this record ?

Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience

L. Tavares, A. Lador, S. Fuentes, A. Da-Wariboko, K. Blaszyk, K. Malaczynska-Rajpold, G. Papiashvili, S. Korolev, P. Peichl, J. Kautzner, M. Webber, D. Hooks, M. Rodríguez-Mañero, D. Di Toro, C. Labadet, T. Sasaki, K. Okishige, A. Patel, PA....

. 2020 ; 6 (11) : 1420-1431. [pub] 20200930

Language English Country United States

Document type Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21026474

OBJECTIVES: The aim of this study was to assess the long-term efficacy and outcomes of retrograde venous ethanol ablation in treating ventricular arrhythmias (VAs). BACKGROUND: Retrograde coronary venous ethanol ablation (RCVEA) can be effective for radiofrequency ablation (RFA)-refractory VAs, particularly those arising in the LV summit (LVS). METHODS: Patients with drug and RFA-refractory VAs were considered for RCVEA after RF failure attempts. Intramural coronary veins (tributaries of the great cardiac, anterior interventricular, lateral cardiac, posterolateral, and middle cardiac) were mapped using an angioplasty wire. Ethanol infusion was delivered in veins with appropriate signals. RESULTS: Of 63 patients (age 63 ± 14 years; 60% men) with VAs (71% extrasystole, 29% ventricular tachycardia, 76% LVS origin), RCVEA was performed in 56 patients who had suitable vein branches. These were defined as those amenable to cannulation and with intramural signals that preceded those mapped in the epicardium or endocardium and had better matching pace maps or entrainment responses. Seven patients had no suitable veins and underwent RFA. In 38 of 56 (68%) patients, the VAs were successfully terminated exclusively with ethanol infusion. In 17 of 56 (30%) patients, successful ablation was achieved using ethanol with adjunctive RFA in the vicinity of the infused vein due to acute recurrence or ethanol-induced change in VA morphology. Overall, isolated or adjuvant RCVEA was successful in 55 of 56 (98%) patients. At 1-year follow-up, 77% of patients were free of recurrent arrhythmias. Procedural complications included 2 venous dissections that led to pericardial effusions. CONCLUSIONS: RCVEA offers a significant long-term effective treatment for patients with drug and RF-refractory VAs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026474
003      
CZ-PrNML
005      
20211026132900.0
007      
ta
008      
211013s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacep.2020.07.023 $2 doi
035    __
$a (PubMed)33121671
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tavares, Liliana $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
245    10
$a Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience / $c L. Tavares, A. Lador, S. Fuentes, A. Da-Wariboko, K. Blaszyk, K. Malaczynska-Rajpold, G. Papiashvili, S. Korolev, P. Peichl, J. Kautzner, M. Webber, D. Hooks, M. Rodríguez-Mañero, D. Di Toro, C. Labadet, T. Sasaki, K. Okishige, A. Patel, PA. Schurmann, AS. Dave, TG. Rami, M. Valderrábano
520    9_
$a OBJECTIVES: The aim of this study was to assess the long-term efficacy and outcomes of retrograde venous ethanol ablation in treating ventricular arrhythmias (VAs). BACKGROUND: Retrograde coronary venous ethanol ablation (RCVEA) can be effective for radiofrequency ablation (RFA)-refractory VAs, particularly those arising in the LV summit (LVS). METHODS: Patients with drug and RFA-refractory VAs were considered for RCVEA after RF failure attempts. Intramural coronary veins (tributaries of the great cardiac, anterior interventricular, lateral cardiac, posterolateral, and middle cardiac) were mapped using an angioplasty wire. Ethanol infusion was delivered in veins with appropriate signals. RESULTS: Of 63 patients (age 63 ± 14 years; 60% men) with VAs (71% extrasystole, 29% ventricular tachycardia, 76% LVS origin), RCVEA was performed in 56 patients who had suitable vein branches. These were defined as those amenable to cannulation and with intramural signals that preceded those mapped in the epicardium or endocardium and had better matching pace maps or entrainment responses. Seven patients had no suitable veins and underwent RFA. In 38 of 56 (68%) patients, the VAs were successfully terminated exclusively with ethanol infusion. In 17 of 56 (30%) patients, successful ablation was achieved using ethanol with adjunctive RFA in the vicinity of the infused vein due to acute recurrence or ethanol-induced change in VA morphology. Overall, isolated or adjuvant RCVEA was successful in 55 of 56 (98%) patients. At 1-year follow-up, 77% of patients were free of recurrent arrhythmias. Procedural complications included 2 venous dissections that led to pericardial effusions. CONCLUSIONS: RCVEA offers a significant long-term effective treatment for patients with drug and RF-refractory VAs.
650    _2
$a srdeční arytmie $7 D001145
650    12
$a ethanol $7 D000431
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a perikard $7 D010496
650    12
$a komorová tachykardie $x farmakoterapie $7 D017180
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lador, Adi $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Fuentes, Stephanie $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Da-Wariboko, Akanibo $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Blaszyk, Krzysztof $u Poznan University of Medical Sciences, Poznan, Poland
700    1_
$a Malaczynska-Rajpold, Katarzyna $u Poznan University of Medical Sciences, Poznan, Poland
700    1_
$a Papiashvili, Giorgi $u Arrhythmia Unit, Jo Ann Medical Center, Tbilisi, Georgia, USA
700    1_
$a Korolev, Sergey $u Federal Research and Clinical Center of the FMBA of Russia, Moscow, Russia
700    1_
$a Peichl, Petr $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Kautzner, Josef $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Webber, Matthew $u Wellington Hospital, Wellington, New Zealand
700    1_
$a Hooks, Darren $u Wellington Hospital, Wellington, New Zealand
700    1_
$a Rodríguez-Mañero, Moisés $u Arrhythmia Unit, Complexo Hospitalario de Santiago de Compostela, A Coruña, Spain
700    1_
$a Di Toro, Darío $u Hospital CEMIC, Buenos Aires, Argentina
700    1_
$a Labadet, Carlos $u Hospital CEMIC, Buenos Aires, Argentina
700    1_
$a Sasaki, Takeshi $u Heart Rhythm Center, National Hospital Organization Disaster Medical Center, Tokyo, Japan
700    1_
$a Okishige, Kaoru $u Heart Center, Japan Red Cross Yokohama City Bay Hospital, Yokohama, Japan
700    1_
$a Patel, Apoor $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Schurmann, Paul A $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Dave, Amish S $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Rami, Tapan G $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
700    1_
$a Valderrábano, Miguel $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: mvalderrabano@houstonmethodist.org
773    0_
$w MED00193518 $t JACC. Clinical electrophysiology $x 2405-5018 $g Roč. 6, č. 11 (2020), s. 1420-1431
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33121671 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132906 $b ABA008
999    __
$a ok $b bmc $g 1715253 $s 1146981
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 6 $c 11 $d 1420-1431 $e 20200930 $i 2405-5018 $m JACC. Clinical electrophysiology $n JACC Clin Electrophysiol $x MED00193518
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Archiving options